Report of a first-in-human study of the first-in-class fatty acid synthase (FASN) inhibitor TVB-2640

Category Primary study
JournalCancer Research
Year 2015
This article has no abstract
Epistemonikos ID: fd58c52e9c6062b400c9889e580f46fe9ed51b2c
First added on: Feb 07, 2025